SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-110064
Filing Date
2024-04-24
Accepted
2024-04-24 16:06:17
Documents
19
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d590894ddef14a.htm   iXBRL DEF 14A 927089
6 GRAPHIC g590894dsp082.jpg GRAPHIC 155518
7 GRAPHIC g590894dsp083.jpg GRAPHIC 123434
8 GRAPHIC g590894g09j53.jpg GRAPHIC 23706
9 GRAPHIC g590894g44i65.jpg GRAPHIC 30499
10 GRAPHIC g590894g52j42.jpg GRAPHIC 24135
  Complete submission text file 0001193125-24-110064.txt   2523074

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kymr-20231231.xsd EX-101.SCH 4313
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kymr-20231231_def.xml EX-101.DEF 3734
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kymr-20231231_lab.xml EX-101.LAB 4945
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kymr-20231231_pre.xml EX-101.PRE 2991
22 EXTRACTED XBRL INSTANCE DOCUMENT d590894ddef14a_htm.xml XML 153760
Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39460 | Film No.: 24870580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)